Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC90521Ornipressin (acetate)CAS: 914453-98-8Purity: >98.00%
Ein synthetisches Peptidderivat von Vasopressin.
- GC90529Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt)Purity: >95.00%
Ein Peptid-Substrat für PKC
- GC90603Tat-CIRP (trifluoroacetate salt)Purity: >95.00%
Ein Peptid-Inhibitor der MD-2-CIRP Protein-Protein-Interaktion
- GC90779Shepherdin (trifluoroacetate salt)Purity: >90.00%
Ein Hemmstoff der Survivin-Hsp90-Interaktion.
- GC908402-Chloroadenosine-5'-O-diphosphate (sodium salt)CAS: 82927-78-4Purity: >95.00%
Eine Ableitung von ADP.
- GC90893Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-89-5Purity: >95.00%
Ein Isomer von ADP-α-S
- GC90894Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt)CAS: 2005478-90-8Purity: >95.00%
Ein Isomer von ADP-α-S
- GC91042Tauro-Obeticholic Acid (sodium salt)CAS: 2278141-79-8Purity: >98.00%
Ein aktiver Metabolit von Obeticholsäure.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC90483 | Magainin 1 (trifluoroacetate salt) | - | >95.00% | |
Ein antimikrobielles kationisches Peptid | ||||
| GC90490 | PMX-53 (trifluoroacetate salt) | 514814-99-4 | >95.00% | |
Ein C5a-Rezeptor-Antagonist | ||||
| GC90516 | VK-II-86 | 955371-84-3 | >90.00% | |
Ein Inhibitor von SOICR | ||||
| GC90521 | Ornipressin (acetate) | 914453-98-8 | >98.00% | |
Ein synthetisches Peptidderivat von Vasopressin. | ||||
| GC90526 | st-Ht31 (ammonium salt) | - | >98.00% | |
Eine zellpermeable, stearatierte Peptid. | ||||
| GC90529 | Myelin Basic Protein Peptide (mouse, bovine) (trifluoroacetate salt) | - | >95.00% | |
Ein Peptid-Substrat für PKC | ||||
| GC90546 | MOG Peptide (human, bovine) (acetate) | - | >95.00% | |
Ein endogenes Myelinscheiden-Peptid | ||||
| GC90554 | E70K (trifluoroacetate salt) | - | >98.00% | |
Ein Peptid-Inhibitor der CXCL8-GAG-Interaktion | ||||
| GC90603 | Tat-CIRP (trifluoroacetate salt) | - | >95.00% | |
Ein Peptid-Inhibitor der MD-2-CIRP Protein-Protein-Interaktion | ||||
| GC90672 | L202 | 2170488-92-1 | >95.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC90684 | Lipid 2,2(8,8) 4C CH3 | 2230647-30-8 | >95.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC90697 | Docosahexaenoic Acid-d5 ethyl ester | 159146-01-7 | >99.00% | |
Nicht verfügbar | ||||
| GC90700 | Dendrogenin A | 1191043-85-2 | >95.00% | |
Ein selektiver LXR-Modulator und ChEH-Inhibitor | ||||
| GC90750 | cKK-E15 | 1432494-71-7 | >95.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC90772 | YK-009 | 2761458-86-8 | >95.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC90779 | Shepherdin (trifluoroacetate salt) | - | >90.00% | |
Ein Hemmstoff der Survivin-Hsp90-Interaktion. | ||||
| GC90822 | LAU-0901 | 727358-25-0 | >95.00% | |
Ein PAF-Rezeptor-Antagonist | ||||
| GC90840 | 2-Chloroadenosine-5'-O-diphosphate (sodium salt) | 82927-78-4 | >95.00% | |
Eine Ableitung von ADP. | ||||
| GC90893 | Rp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-89-5 | >95.00% | |
Ein Isomer von ADP-α-S | ||||
| GC90894 | Sp-Adenosine-5'-O-(1-thiodiphosphate) (sodium salt) | 2005478-90-8 | >95.00% | |
Ein Isomer von ADP-α-S | ||||
| GC90929 | Trofinetide (acetate) | - | >95.00% | |
Eine Ableitung von Gly-Pro-Glu. | ||||
| GC90993 | CL4F8-6 | 2766493-12-1 | >98.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC91028 | L-K6L9 (trifluoroacetate salt) | - | >98.00% | |
Ein zytolytisches Peptid | ||||
| GC91042 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | >98.00% | |
Ein aktiver Metabolit von Obeticholsäure. | ||||